The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Open accessAbstract
BACKGROUND: Although we know that exacerbations are key events in chronic obstructive pulmonary disease (COPD), our understanding of their frequency, determinants, and effects is incomplete. In a large observational cohort, we tested the hypothesis that there is a frequent-exacerbation phenotype of COPD that is independent of disease severity. METHODS: We analyzed the frequency and associations of exacerbation in 2138 patients enrolled in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study. Exacerbations were defined as events that led a care provider to prescribe antibiotics or corticosteroids (or both) or that led to hospitalization (severe exacerbations). Exacerbation frequency was observed over a period of 3 years. RESULTS: Exacerbations became more frequent (and more severe) as the severity of COPD increased; exacerbation rates in the first year of follow-up were 0.85 per person for patients with stage 2 COPD (with stage defined in accordance with Global Initiative for Chronic Obstructive Lung Disease [GOLD] stages), 1.34 for patients with stage 3, and 2.00 for patients with stage 4. Overall, 22% of patients with stage 2 disease, 33% with stage 3, and 47% with stage 4 had frequent exacerbations (two or more in the first year of follow-up). The single best predictor of exacerbations, across all GOLD stages, was a history of exacerbations. The frequent-exacerbation phenotype appeared to be relatively stable over a period of 3 years and could be predicted on the basis of the patient's recall of previous treated events. In addition to its association with more severe disease and prior exacerbations, the phenotype was independently associated with a history of gastroesophageal reflux or heartburn, poorer quality of life, and elevated white-cell count. CONCLUSIONS: Although exacerbations become more frequent and more severe as COPD progresses, the rate at which they occur appears to reflect an independent susceptibility phenotype. This has implications for the targeting of exacerbation-prevention strategies across the spectrum of disease severity. (Funded by GlaxoSmithKline; ClinicalTrials.gov number, NCT00292552.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationCelli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Self-citationBestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Self-citationEffect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Self-citationDonaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Soler-Cataluna, J. J. (2005) · Thorax · doi:10.1136/thx.2005.040527 · Cited by 1,931
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604
COPD exacerbations: Defining their cause and prevention
Wedzicha, J. A., & Seemungal, T. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61382-8 · Cited by 1,370
Self-citation
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationVogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0218pp · Cited by 3,187
Self-citationGlobal Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00239-2023 · Cited by 1,303
Self-citationBafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0597oc · Cited by 1,094
Self-citationTreatable traits: toward precision medicine of chronic airway diseases
Agusti, A., Bel, E., Thomas, M., Vogelmeier, C., Brusselle, G., Holgate, S., Humbert, M., Jones, P., Gibson, P. G., Vestbo, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01359-2015 · Cited by 1,083
Self-citationChronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
Changes in Forced Expiratory Volume in 1 Second over Time in COPD
Vestbo, J., Edwards, L. D., Scanlon, P. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. M. A., Celli, B., Coxson, H. O., Crim, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105482 · Cited by 963
Self-citationVogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00214-2017 · Cited by 881
Self-citationRochester, C. L., Vogiatzis, I., Holland, A. E., Lareau, S. C., Marciniuk, D. D., Puhan, M. A., Spruit, M. A., Masefield, S., Casaburi, R., Clini, E. M., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-1966st · Cited by 856
Agustí, A., Edwards, L. D., Rennard, S. I., MacNee, W., Tal-Singer, R., Miller, B. E., Vestbo, J., Lomas, D. A., Calverley, P. M. A., Wouters, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037483 · Cited by 848
Self-citationGlobal Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0106pp · Cited by 827
Self-citationSuissa, S., Dell'Aniello, S., & Ernst, P. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201518 · Cited by 779
New insights into the immunology of chronic obstructive pulmonary disease
Brusselle, G. G., Joos, G. F., & Bracke, K. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60988-4 · Cited by 776
Chronic obstructive pulmonary disease
Barnes, P. J., Burney, P. G. J., Silverman, E. K., Celli, B. R., Vestbo, J., Wedzicha, J. A., & Wouters, E. F. M. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.76 · Cited by 734
Self-citationTiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
Vogelmeier, C., Hederer, B., Glaab, T., Schmidt, H., Rutten-van Mölken, M. P. M. H., Beeh, K. M., Rabe, K. F., & Fabbri, L. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008378 · Cited by 684
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Wedzicha, J. A., Miravitlles, M., Hurst, J. R., Calverley, P. M. A., Albert, R. K., Anzueto, A., Criner, G. J., Papi, A., Rabe, K. F., Rigau, D., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00791-2016 · Cited by 683
Self-citationVogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Respirology · doi:10.1111/resp.13012 · Cited by 681
Self-citationPapi, A., Vestbo, J., Fabbri, L., Corradi, M., Prunier, H., Cohuet, G., Guasconi, A., Montagna, I., Vezzoli, S., Petruzzelli, S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30206-x · Cited by 603
Self-citationThe Lung Tissue Microbiome in Chronic Obstructive Pulmonary Disease
Sze, M. A., Dimitriu, P. A., Hayashi, S., Elliott, W. M., McDonough, J. E., Gosselink, J. V., Cooper, J., Sin, D. D., Mohn, W. W., & Hogg, J. C. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2075oc · Cited by 552
Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease
Agustí, A., & Hogg, J. C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1900475 · Cited by 551
Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity
Flume, P. A., Chalmers, J. D., & Olivier, K. N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31767-7 · Cited by 545
Risk factors and early origins of chronic obstructive pulmonary disease
Postma, D. S., Bush, A., & van den Berge, M. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60446-3 · Cited by 541
Wedzicha, J. A., Decramer, M., Ficker, J. H., Niewoehner, D. E., Sandström, T., Taylor, A. F., D'Andrea, P., Arrasate, C., Chen, H., & Banerji, D. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70052-3 · Cited by 535
Self-citationThe role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495
Pulmonary Arterial Enlargement and Acute Exacerbations of COPD
Wells, J. M., Washko, G. R., Han, M. K., Abbas, N., Nath, H., Mamary, A. J., Regan, E., Bailey, W. C., Martinez, F. J., Westfall, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203830 · Cited by 499
Association Between Interstitial Lung Abnormalities and All-Cause Mortality
Putman, R. K., Hatabu, H., Araki, T., Gudmundsson, G., Gao, W., Nishino, M., Okajima, Y., Dupuis, J., Latourelle, J. C., Cho, M. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.0518 · Cited by 473
Self-citationGuidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 468
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease
Celli, B. R., & Wedzicha, J. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1900500 · Cited by 461
Self-citationSchram, M. T., Sep, S. J. S., van der Kallen, C. J., Dagnelie, P. C., Koster, A., Schaper, N., Henry, R. M. A., & Stehouwer, C. D. A. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9889-0 · Cited by 457
Han, M. K., Kazerooni, E. A., Lynch, D. A., Liu, L. X., Murray, S., Curtis, J. L., Criner, G. J., Kim, V., Bowler, R. P., Hanania, N. A., et al. (2011) · Radiology · doi:10.1148/radiol.11110173 · Cited by 453
Self-citationCOPD Guidelines: A Review of the 2018 GOLD Report
Mirza, S., Clay, R. D., Koslow, M. A., & Scanlon, P. D. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.05.026 · Cited by 444
Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations
Denlinger, L. C., Phillips, B. R., Ramratnam, S., Ross, K., Bhakta, N. R., Cardet, J. C., Castro, M., Peters, S. P., Phipatanakul, W., Aujla, S., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201602-0419oc · Cited by 435
The clinical features of the overlap between COPD and asthma
the COPDGene Investigators, Hardin, M., Silverman, E. K., Barr, R. G., Hansel, N. N., Schroeder, J. D., Make, B. J., Crapo, J. D., & Hersh, C. P. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-127 · Cited by 428
The clinical and economic burden of chronic obstructive pulmonary disease in the USA
Ray, S., Guarascio, Finch, & Self, T. (2013) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s34321 · Cited by 425
Epidemiology and clinical impact of major comorbidities in patients with COPD
Smith, M., & Wrobel, J. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s49621 · Cited by 407
Ritchie, A. I., & Wedzicha, J. A. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.06.007 · Cited by 402
Self-citationInflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease
Thomsen, M., Ingebrigtsen, T. S., Marott, J. L., Dahl, M., Lange, P., Vestbo, J., & Nordestgaard, B. G. (2013) · JAMA · doi:10.1001/jama.2013.5732 · Cited by 401
Self-citationDesign of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1
Couper, D., LaVange, L. M., Han, M., Barr, R. G., Bleecker, E., Hoffman, E. A., Kanner, R., Kleerup, E., Martinez, F. J., Woodruff, P. G., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-203897 · Cited by 394
Self-citationFerguson, G. T., Rabe, K. F., Martinez, F. J., Fabbri, L. M., Wang, C., Ichinose, M., Bourne, E., Ballal, S., Darken, P., DeAngelis, K., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30327-8 · Cited by 379
Miravitlles, M., Soler-Cataluña, J. J., Calle, M., Molina, J., Almagro, P., Quintano, J. A., Trigueros, J. A., Cosío, B. G., Casanova, C., Antonio Riesco, J., et al. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2017.03.018 · Cited by 378
Lehouck, A., Mathieu, C., Carremans, C., Baeke, F., Verhaegen, J., Van Eldere, J., Decallonne, B., Bouillon, R., Decramer, M., & Janssens, W. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-2-201201170-00004 · Cited by 363
Lange, P., Marott, J. L., Vestbo, J., Olsen, K. R., Ingebrigtsen, T. S., Dahl, M., & Nordestgaard, B. G. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1299oc · Cited by 362
Self-citationCharacterization of the “Frequent Exacerbator Phenotype” in Bronchiectasis
Chalmers, J. D., Aliberti, S., Filonenko, A., Shteinberg, M., Goeminne, P. C., Hill, A. T., Fardon, T. C., Obradovic, D., Gerlinger, C., Sotgiu, G., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201711-2202oc · Cited by 351
Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD
Criner, G. J., Connett, J. E., Aaron, S. D., Albert, R. K., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Curtis, J. L., Dransfield, M. T., Han, M. K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403086 · Cited by 347
Dransfield, M. T., Bourbeau, J., Jones, P. W., Hanania, N. A., Mahler, D. A., Vestbo, J., Wachtel, A., Martinez, F. J., Barnhart, F., Sanford, L., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70040-7 · Cited by 345
Self-citationPolkey, M. I., Spruit, M. A., Edwards, L. D., Watkins, M. L., Pinto-Plata, V., Vestbo, J., Calverley, P. M. A., Tal-Singer, R., Agustí, A., Bakke, P. S., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1596oc · Cited by 329
Self-citationGreene, C. M., Marciniak, S. J., Teckman, J., Ferrarotti, I., Brantly, M. L., Lomas, D. A., Stoller, J. K., & McElvaney, N. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.51 · Cited by 324
Self-citationThe Chronic Bronchitic Phenotype of COPD
Kim, V., Han, M. K., Vance, G. B., Make, B. J., Newell, J. D., Hokanson, J. E., Hersh, C. P., Stinson, D., Silverman, E. K., & Criner, G. J. (2011) · Chest · doi:10.1378/chest.10-2948 · Cited by 323
Tantucci, C., & Modina, D. (2012) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s27480 · Cited by 321
Hospitalized Exacerbations of COPD
Müllerova, H., Maselli, D. J., Locantore, N., Vestbo, J., Hurst, J. R., Wedzicha, J. A., Bakke, P., Agusti, A., & Anzueto, A. (2015) · Chest · doi:10.1378/chest.14-0655 · Cited by 320
Self-citationHan, M. K., Quibrera, P. M., Carretta, E. E., Barr, R. G., Bleecker, E. R., Bowler, R. P., Cooper, C. B., Comellas, A., Couper, D. J., Curtis, J. L., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30207-2 · Cited by 319
Self-citationReduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis
Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Mendes, R. G., Alghamdi, S. M., Miravitlles, M., Mandal, S., & Hurst, J. R. (2021) · PLOS ONE · doi:10.1371/journal.pone.0255659 · Cited by 316
Self-citationVogelmeier, C. F., Bateman, E. D., Pallante, J., Alagappan, V. K., D'Andrea, P., Chen, H., & Banerji, D. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(12)70052-8 · Cited by 314
Inflammatory endotypes in COPD
Barnes, P. J. (2019) · Allergy · doi:10.1111/all.13760 · Cited by 313
COPD and its comorbidities: Impact, measurement and mechanisms
Negewo, N. A., Gibson, P. G., & McDonald, V. M. (2015) · Respirology · doi:10.1111/resp.12642 · Cited by 311
Pinnock, H., Hanley, J., McCloughan, L., Todd, A., Krishan, A., Lewis, S., Stoddart, A., van der Pol, M., MacNee, W., Sheikh, A., et al. (2013) · BMJ · doi:10.1136/bmj.f6070 · Cited by 310
Self-citationVogelmeier, C. F., Criner, G. J., Martínez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2017.02.001 · Cited by 309
Self-citationHistone deacetylase 6–mediated selective autophagy regulates COPD-associated cilia dysfunction
Lam, H. C., Cloonan, S. M., Bhashyam, A. R., Haspel, J. A., Singh, A., Sathirapongsasuti, J. F., Cervo, M., Yao, H., Chung, A. L., Mizumura, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69636 · Cited by 307
The clinical and genetic features of COPD-asthma overlap syndrome
Hardin, M., Cho, M., McDonald, M.-L., Beaty, T., Ramsdell, J., Bhatt, S., van Beek, E. J. R., Make, B. J., Crapo, J. D., Silverman, E. K., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00216013 · Cited by 294
Uzun, S., Djamin, R. S., Kluytmans, J. A. J. W., Mulder, P. G. H., van't Veer, N. E., Ermens, A. A. M., Pelle, A. J., Hoogsteden, H. C., Aerts, J. G. J. V., & van der Eerden, M. M. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70019-0 · Cited by 293
Rennard, S. I., Calverley, P. M., Goehring, U. M., Bredenbröker, D., & Martinez, F. J. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-18 · Cited by 284
Self-citationViniol, C., & Vogelmeier, C. F. (2018) · European Respiratory Review · doi:10.1183/16000617.0103-2017 · Cited by 283
At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease
Martinez, F. J., Han, M. K., Allinson, J. P., Barr, R. G., Boucher, R. C., Calverley, P. M. A., Celli, B. R., Christenson, S. A., Crystal, R. G., Fagerås, M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201710-2028pp · Cited by 282
Self-citationSystemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Walters, J. A., Gibson, P. G., Wood-Baker, R., Hannay, M., & Walters, E. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001288.pub3 · Cited by 279
C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations
Butler, C. C., Gillespie, D., White, P., Bates, J., Lowe, R., Thomas-Jones, E., Wootton, M., Hood, K., Phillips, R., Melbye, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803185 · Cited by 277
Coxson, H. O., Dirksen, A., Edwards, L. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. M., Celli, B., Crim, C., Duvoix, A., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70006-7 · Cited by 274
Self-citationMallia, P., Footitt, J., Sotero, R., Jepson, A., Contoli, M., Trujillo-Torralbo, M.-B., Kebadze, T., Aniscenko, J., Oleszkiewicz, G., Gray, K., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0806oc · Cited by 274
Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
Faner, R., Rojas, M., MacNee, W., & Agustí, A. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0282pp · Cited by 268
Self-citationSchmidt, M., Dekker, F. J., & Maarsingh, H. (2013) · Pharmacological Reviews · doi:10.1124/pr.110.003707 · Cited by 267
Integrated disease management interventions for patients with chronic obstructive pulmonary disease
Kruis, A. L., Smidt, N., Assendelft, W. J., Gussekloo, J., Boland, M. R., Rutten-van Mölken, M., & Chavannes, N. H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009437.pub2 · Cited by 259
Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review
Riley, C. M., & Sciurba, F. C. (2019) · JAMA · doi:10.1001/jama.2019.0131 · Cited by 258
Zheng, J.-P., Wen, F.-Q., Bai, C.-X., Wan, H.-Y., Kang, J., Chen, P., Yao, W.-Z., Ma, L.-J., Li, X., Raiteri, L., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70286-8 · Cited by 258
Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
Miravitlles, M., Soler-Cataluña, J. J., Calle, M., Molina, J., Almagro, P., Quintano, J. A., Riesco, J. A., Trigueros, J. A., Piñera, P., Simón, A., et al. (2012) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2012.04.001 · Cited by 257
Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease
Sze, M. A., Dimitriu, P. A., Suzuki, M., McDonough, J. E., Campbell, J. D., Brothers, J. F., Erb-Downward, J. R., Huffnagle, G. B., Hayashi, S., Elliott, W. M., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0223oc · Cited by 254
Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
Wedzicha, J. A., Brill, S. E., Allinson, J. P., & Donaldson, G. C. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-181 · Cited by 253
Self-citationLung ageing and COPD: is there a role for ageing in abnormal tissue repair?
Brandsma, C.-A., de Vries, M., Costa, R., Woldhuis, R. R., Königshoff, M., & Timens, W. (2017) · European Respiratory Review · doi:10.1183/16000617.0073-2017 · Cited by 221
Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization: A Randomized Study
Benzo, R., Vickers, K., Novotny, P. J., Tucker, S., Hoult, J., Neuenfeldt, P., Connett, J., Lorig, K., & McEvoy, C. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2503oc · Cited by 176
Lim, S., Lam, D. C.-L., Muttalif, A. R., Yunus, F., Wongtim, S., Lan, L. T. T., Shetty, V., Chu, R., Zheng, J., Perng, D.-W., et al. (2015) · Asia Pacific Family Medicine · doi:10.1186/s12930-015-0020-9 · Cited by 167
Alqahtani, J. S., Njoku, C. M., Bereznicki, B., Wimmer, B. C., Peterson, G. M., Kinsman, L., Aldabayan, Y. S., Alrajeh, A. M., Aldhahir, A. M., Mandal, S., et al. (2020) · European Respiratory Review · doi:10.1183/16000617.0166-2019 · Cited by 149
Müllerová, H., Lu, C., Li, H., & Tabberer, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085540 · Cited by 139
Self-citationMacrophage heterogeneity in respiratory diseases
Boorsma, C. E., Draijer, C., & Melgert, B. N. (2013) · Mediators of Inflammation · doi:10.1155/2013/769214 · Cited by 126
Diffusing Capacity of Carbon Monoxide in Assessment of COPD
Balasubramanian, A., MacIntyre, N. R., Henderson, R. J., Jensen, R. L., Kinney, G., Stringer, W. W., Hersh, C. P., Bowler, R. P., Casaburi, R., Han, M. K., et al. (2019) · Chest · doi:10.1016/j.chest.2019.06.035 · Cited by 100
Number needed to treat in COPD: exacerbations versus pneumonias
Suissa, S. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202709 · Cited by 77
Jonkman, N., Westland, H., Trappenburg, J. C., Groenwold, R. H., Bischoff, E. W., Bourbeau, J., Bucknall, C. E., Coultas, D., Effing, T. W., Epton, M., et al. (2016) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s107884 · Cited by 71
The impact of integrated disease management in high-risk COPD patients in primary care
Ferrone, M., Masciantonio, M. G., Malus, N., Stitt, L., O’Callahan, T., Roberts, Z., Johnson, L., Samson, J., Durocher, L., Ferrari, M., et al. (2019) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-019-0119-9 · Cited by 68
Bewley, M. A., Belchamber, K. B. R., Chana, K. K., Budd, R. C., Donaldson, G., Wedzicha, J. A., Brightling, C. E., Kilty, I., Donnelly, L. E., Barnes, P. J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163139 · Cited by 64
Self-citationA multicentre, randomized controlled trial of telehealth for the management of COPD
Soriano, J. B., García-Río, F., Vázquez-Espinosa, E., Conforto, J. I., Hernando-Sanz, A., López-Yepes, L., Galera-Martínez, R., Peces-Barba, G., Gotera-Rivera, C. M., Pérez-Warnisher, M. T., et al. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.10.008 · Cited by 59
Prevalence and Clinical Outcomes of Eosinophilic COPD in a Saudi Population: A Retrospective Study
Alshehri, F., Alghamdi, M., Aloqabi, F. A., Ibrahim, A., Tayeb, N., Hassosah, M., Abu-Zaid, A., Fan, H., & Vali, Y. (2025) · Saudi Journal of Medicine & Medical Sciences · doi:10.4103/sjmms.sjmms_248_24 · Cited by 3
Metadata
- Authors
- Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., Calverley, P., Rennard, S., Wouters, E. F. M., & Wedzicha, J. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-09-16
- Volume
- 363
- Issue
- 12
- Pages
- 1128-1138
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2002726093
- Cited by
- 2,981
- References
- 26
- FWCI
- 125.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.